Catalyst Wire Dossier Catalyst Wire Dossier

Reproxalap

reproxalap · Aldeyra Therapeutics
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Reproxalap, covering 2023-03-01 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 3]

See pricing